Table of Contents
ISRN Pharmacology
Volume 2013 (2013), Article ID 146579, 7 pages
http://dx.doi.org/10.1155/2013/146579
Research Article

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients

1Departments of Pharmacy and Clinical Pharmacy, Hamad General Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar
2Departments of Medicine and Endocrinology, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar
3Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar
4Departments of Public Health and Medical Education, Weill Cornell Medical College in Qatar, P.O. Box 3050, Doha, Qatar
5Department of Evidence for Population Health Unit, School of Epidemiology and Health Sciences, The University of Manchester, Manchester, UK
6Pediatric Intensive Care Unit, Department of Pediatrics, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar

Received 6 December 2012; Accepted 3 January 2013

Academic Editors: T. Kumai and T. B. Vree

Copyright © 2013 Lolwa Barakat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lolwa Barakat, Amin Jayyousi, Abdulbari Bener, Bilal Zuby, and Mahmoud Zirie, “Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients,” ISRN Pharmacology, vol. 2013, Article ID 146579, 7 pages, 2013. doi:10.1155/2013/146579